Equity Story talks about sp falling due to market uncertainties if or whether the LIFX will proceed, but I am thinking it is falling because the numbers don't stack up post-acquisition. The price is too steep for BUD to take on - the irony is when the business has no revenues, everyone focuses on revenues and revenue growth but when the business gains revenue, it looks at EBITDA , profit and cashflow, otherwise stocks like BIQ and CM8 would have prospered. At the beginning, the revenue emphasis mattered because people perceive that when the revenues roll in with y-o-y large revenue growth, EBITDA positive is a given. So revenue only matters if its growth is perceived as being capable of turning the business into positive cashflow- positive cashflow provides assurance of no future rounds of CR.
As my analysis indicate in my previous post, I don't see it happening for at least 5 years and LIFX margins are too low for the business to be profitable anytime soon.
BUD Price at posting:
6.7¢ Sentiment: Sell Disclosure: Not Held